Furthermore, p53 loss negated the survival benefit of NPM1 depletion in Apc-driven CRC models, while most tumors retained NPM1 loss (Fig. 3n–q and Extended Data Fig. 6g–l). The gene discussed is TP53; the disease is colorectal carcinoma.